ALPHARETTA, Ga.--(BUSINESS WIRE)--Spectrum Plastics Group, the market leading medical components and contract manufacturer, is pleased to announce the acquisition of Earnan Biomedical Ltd of Wexford, Ireland. Earnan Biomedical, led by Mr. Colin Sutherland, is a recognized leader in the innovation of medical balloon technologies and solutions. The acquisition represents additional investment for Spectrum Plastics overseas and in Ireland in particular, contributing to its established manufacturing presence and operation in Tullamore.
Spectrum Plastics earlier this year struck a joint-marketing agreement with Earnan and Mr. Sutherland, offering quick-turn, stock balloon solutions “off the shelf” through its Apollo™ web store. Over the last several months the alignment the two companies have witnessed between their respective technical solutions for customers in the catheter systems market has compelled a more formal consummation.
Earnan specializes in the design, development, and manufacture of custom balloon forming technologies. Its suite of capabilities includes textured and non-textured balloons across a wide variety of materials, including nylon, polyurethane, and polyester. Additional developments include multi-layered balloon designs and high-pressure products. Applications range across cardiovascular, gastrointestinal, nutrition, neurovascular, wound care, and orthopedic solutions.
Spectrum Plastics will retain the Earnan name as the brand under which its balloon solutions will be marketed -- Earnan™ balloons by Spectrum Plastics Group. Mr. Sutherland will remain with Spectrum Plastics as Vice President of Balloon Technologies and direct the Wexford, Ireland center of excellence for balloon innovation, which will become part of Spectrum Plastics’ Vascular Technologies division.
Neil Shillingford, Spectrum Plastics CEO, remarks, "It is my pleasure to welcome Colin and Earnan to the Spectrum Plastics Group. Its balloon technology is without peer and will no doubt advance the solutions we provide to our customers and their next generation catheter delivery systems.”
This transaction is the first acquisition of Spectrum Plastics since it acquired Fermatex Vascular Technologies, better known as Adam Spence, in May of 2018. Both transactions have supported its Vascular Technologies division, a focus for growth and expansion for the company.
About Spectrum Plastics Group
Based in Alpharetta, Georgia with multiple plants across the United States, Mexico, Costa Rica, Ireland, and Malaysia, Spectrum Plastics Group is a North American leader in the design and fabrication of custom and specialty plastics products focusing on niche, high value-added end markets, including medical, food, and defense applications. Spectrum Plastics offers a full range of custom design, engineering and fabrication services, as well as meet the requirements of ISO 9001, ISO 13485, and operates multiple Class 7 & Class 8 clean rooms. For more information, visit www.spgindustries.com, www.spectrumplastics.com or contact 404-564-8560.